Annual report [Section 13 and 15(d), not S-K Item 405]

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)

v3.26.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)
12 Months Ended
Dec. 31, 2025
Accounting Policies [Abstract]  
SCHEDULE OF ACCOUNTS RECEIVABLE

Accounts receivable, net comprises the following categories (in thousands):

    2025     2024  
    For the year ended December 31,  
    2025     2024  
             
Product sales   $ 3,147     $  
License revenues     3,000        
Total accounts receivable, net   $ 6,147     $  
SCHEDULE OF NUMERATORS AND DENOMINATORS OF BASIC AND DILUTED NET INCOME (LOSS) PER SHARE AMOUNTS

A reconciliation of the numerators and the denominators of the basic and diluted net income (loss) per share computations are as follows (in thousands, except share and per share amounts):

 

    2025     2024  
    For the year ended December 31,  
    2025     2024  
             
Numerator:                
Net income (loss) used for basic net income (loss) per share   $ 71,183     $ (63,734 )
Effect of dilutive securities:                
Fair value adjustments for warrant liabilities     (4,106 )      
Numerator for dilutive net income (loss) per share - net income (loss) available for common shareholders’ after the effect of dilutive securities   $ 67,077     $ (63,734 )
                 
Denominator:                
Weighted average number of common shares outstanding - basic     52,952,917       41,048,206  
Effect of dilutive shares:                
Shares of common stock issuable upon exercise of stock options     176,170        
Shares of common stock underlying restricted stock     4,581,249        
Shares of common stock issuable upon exercise of warrants     7,811,234        
Shares of common stock issuable upon exercise of conversion feature of loan agreement     614,251        
Dilutive potential common shares     13,182,904        
Denominator for dilutive net income (loss) per share - adjusted weighted average shares used in computing net income (loss) per share - dilutive     66,135,821       41,048,206  
                 
Earnings per share:                
Basic income (loss) per common share   $ 1.34     $ (1.55 )
Dilutive income (loss) per common share   $ 1.01     $ (1.55 )
SCHEDULE OF ANTI-DILUTIVE SECURITIES EXCLUDED FROM COMPUTATION OF EARNINGS PER SHARE

 

    For the year ended December 31,  
    2025     2024  
             
Shares of common stock issuable upon exercise of stock options           176,587  
Shares of common stock underlying restricted stock           3,320,811  
Shares of common stock issuable upon exercise of conversion feature of loan agreement           614,251  
Shares of common stock issuable upon exercise of warrants     1,804,474       9,987,560  
Total     1,804,474       14,099,209